Clinical trial
Precision Medicine in Ischemic Stroke and Atrial Fibrillation
NCT04637087 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Precision Medicine in Ischemic Stroke and Atrial Fibrillation
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 11, 2021
- Completion date
- July 14, 2024
- Enrollment
- 805 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.